T Helper 22 Pathway Evaluation in Type 1 Diabetes and Its Complications.
We report that Th22 pathway is not a good prognostic as well as diagnostic marker of early macrovascular complications in T1D.
PMID: 29908543 [PubMed - in process]
Source: Iranian Journal of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Akbari H, Ghardashi M, Soleimani A, Mohammadi H, Nikoueinejad H Tags: Iran J Allergy Asthma Immunol Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Diabetes | Diabetes Type 1 | Endocrinology | Iran Health | Middle East Health | Study